C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy
C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy
批准号:
9289824
负责人:
MARY ANN Y JABRA-RIZK
金额:
$38.73万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-21 至 2021-06-30
关键词:
AdhesionsAdultAnimal ModelAntimicrobial ResistanceAtomic Force MicroscopyBacteremiaBindingCandida albicansCathetersCellsChildClinicalComplexDataDiseaseDrug resistanceEnsureEvaluationGene ExpressionGenerationsGenesGenetic TranscriptionGenus staphylococcusGoalsHumanHuman bodyImaging DeviceImplantIn VitroInfectionInnate Immune SystemInvestigationLeadMedical DeviceMicrobial BiofilmsMicroscopyMolecularMonitorMorbidity - disease rateOrganismOutcomePathogenicityPathway interactionsPatientsPhenotypePopulationReportingResistance developmentRisk FactorsSignal TransductionSpectrum AnalysisStaphylococcus aureusStressSurfaceSystemTestingTissuesTreatment FailureValidationVirulenceWorkantimicrobialbioluminescence imagingcandidemiaclinically relevantco-infectioncomparativedesigndifferential expressiondrug developmentimaging systemimplantable devicein vitro Modelin vivoinsightintravital imagingintravital microscopymicrobialmicroorganismmicroorganism interactionmortalitymouse modelmutantnew therapeutic targetpathogenresponsesubcutaneoustooltranscriptometranscriptome sequencingtranscriptomicstreatment strategy
中文摘要
项目摘要
葡萄球菌和C.白色念珠菌是最常见的微生物分离组合
多种微生物感染C. albicans和S.金黄色葡萄球菌致病
这在很大程度上取决于它们形成生物膜并相应改变其转录组的能力
以确保在宿主体内存活转录水平的变化
网络还确保这些生物体能够在组织中生长并在压力下生存
先天免疫系统的细胞对它们造成的伤害。显著增强,
C.对抗生素的体外耐受性白色念珠菌和葡萄球菌混合生物膜
被举报。因此,除了形成增强的和持久的
生物膜、与S. aureus和C.白色念珠菌可能影响基因表达,
反过来影响毒力和耐药性。因此,当务之急是
阐明这些病原体在多微生物生物膜内的独特相互作用
在体内的目标是提供全面的见解,如何混合的动态-
微生物种群在人体内建立和调节。为此我们
开发了一种实用的和临床相关的皮下导管小鼠模型,
描述了S. aureus和C.白色念珠菌,因为他们共同-
通过对单个和混合病毒进行比较转录组学分析来感染宿主,
物种生物膜此外,我们设计了可行的非侵入性生物发光成像
和活体显微镜系统作为工具,我们将用它来阐明
生物膜形成机制和体内耐药性的发展
条件我们的中心假设是,调控和转录途径
在体内生长的C. albicans和S.
金黄色葡萄球菌鉴定增强致病潜力的微生物表型,
生物膜相关的多种微生物感染的持久性和抗菌素耐药性。
英文摘要
Project Summary
Staphylococci and C. albicans are the most frequent combination of organisms isolated
from polymicrobial infections. The ability of C. albicans and S. aureus to cause disease
largely depends on their ability to form biofilms and alter their transcriptome in response
to different stresses to ensure survival in the host. Changes in the transcriptional
network also ensure that these organisms can grow in tissues and survive stresses
inflicted upon them by cells of the innate immune system. Significantly, enhanced in
vitro tolerance to antimicrobials in C. albicans and staphylococci mixed biofilms has
been reported. Consequently, in addition to formation of enhanced and persistent
biofilms, co-infection with S. aureus and C. albicans may influence gene expression, in
turn impacting virulence and drug resistance. Therefore, it has become imperative to
elucidate the unique interactions between these pathogens within polymicrobial biofilms
in vivo with the goal of providing overall insights into the dynamics of how mixed-
microbial populations are established and regulated in the human body. To that end, we
developed a practical and clinically-relevant subcutaneous catheter mouse model to
characterize the molecular interplay between S. aureus and C. albicans as they co-
infect a host by performing comparative transcriptomics analysis of single and mixed-
species biofilms. Further, we designed feasible non-invasive bioluminescence imaging
and intravital microscopy systems as tools, which we will use to elucidate the
mechanisms of biofilm formation and development of drug resistance under in vivo
conditions. Our central hypothesis is that the regulatory and transcriptional pathways
uniquely expressed during in vivo-grown polymicrobial biofilms of C. albicans and S.
aureus identify microbial phenotypes of enhanced pathogenic potential central to the
persistence and antimicrobial resistance of biofilm-associated polymicrobial infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections
-
批准号:10429036
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2022
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections
-
批准号:10594559
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2022
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
"Acquisition of a Multi-functional Cryo Scanning Electron Microscope (SEM)"
-
批准号:10175680
-
项目类别:
-
资助金额:$85.49万
-
财政年份:2021
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Candida albicans and Staphylococcus aureus dual species biofilms
-
批准号:8282943
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2010
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Candida albicans and Staphylococcus aureus dual species biofilms
-
批准号:8495762
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2010
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Candida albicans and Staphylococcus aureus dual species biofilms
-
批准号:8689760
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2010
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Candida albicans and Staphylococcus aureus dual species biofilms
-
批准号:8084204
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2010
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Receptor Affects Fungal Mucosal Colonization in HIV
-
批准号:6915766
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
Receptor Affects Fungal Mucosal Colonization in HIV
-
批准号:6841772
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2004
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:7074825
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:6902145
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:6779857
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:6909876
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:6651153
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.
-
批准号:6531284
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2002
-
负责人:MARY ANN Y JABRA-RIZK
-
依托单位:
海外基金